References
- Weinstein M. C., Stason WB. Hypertension: A Policy Perspective. Massachusetts: Harvard University Press, Cambridge 1976
- Jönsson B. Cost-benefit of treating hypertension. Journal of Hypertension 1994; 12(suppl 10)S65–70
- Moderately Elevated Blood Pressure. A report from SBU, The Swedish Council on Technology Assessment in Health Care. Journal of Internal Medicine, vol 238, supplement 737 1995
- Johannesson Magnus Jönsson B. A Review of Cost-Effectiveness Analyses of Hypertension Treatment. PharmacoEconomics 1992; 1(4)250–264, Adis International Limited.
- Johannesson Magnus, Meltzer MD, O'Conor Richard M. Incorporating Future Costs in Medical Cost-Effectiveness Analysis: Implications for the Cost-Effectiveness of the Treatment of Hypertension. Med Decis Making 1997; 17: 382–389
- Hansson Lennart, Zanchetti Alberto, Carruthers S George, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the. Hypertension Optimal Treatment (HOT) randomised trial, The Lancet, vol 351. June 13, 1998
- Johannesson M, Dahlöf B, Lindholm L.H., et al. The cost-effectiveness of treating hypertension in elderly people—an analysis of the Swedish Trail in Old Patients with Hypertension (STOP Hypertension). Journal of Internal Medicine 1993; 234: 317–323
- Johannesson Magnus. The Impact of Age on the Cost-Effectiveness of Hypertension Treatment, An Analysis of Randomized Drug Trials. Med Decis Making 1994; 14: 236–244